On the public citation graph
Benefits of the Continuous Use of 6-MP/MTX with Pulses of VCR/DEX in Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report from South China Children's Leukemia Group
0 signed · 25 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamaoncol.2015.0245openalex-extracted
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia
inferredcites →https://doi.org/10.1002/1097-0142(19880401)61:7<1292::aid-cncr2820610703>3.0.co;2-oopenalex-extracted
Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811)
inferredcites →https://doi.org/10.1002/cpt.1304openalex-extracted
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes: 2018 Update
inferredcites →https://doi.org/10.1002/jha2.27openalex-extracted
Immune reconstitution in children following chemotherapy for acute leukemia
inferredcites →https://doi.org/10.1002/pbc.21889openalex-extracted
Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low‐income countries: A proposal
inferredcites →https://doi.org/10.1002/pbc.26928openalex-extracted
Isolated late testicular relapse of B‐cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response‐based testicular radiation: A Children's Oncology Group study
inferredcites →https://doi.org/10.1002/pbc.28418openalex-extracted
Maintenance therapy of childhood acute lymphoblastic leukemia: Do all roads lead to Rome?
inferredcites →https://doi.org/10.1007/s11864-019-0603-zopenalex-extracted
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
inferredcites →https://doi.org/10.1016/j.clml.2019.10.016openalex-extracted
Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells
inferredcites →https://doi.org/10.1016/s1470-2045(18)30295-xopenalex-extracted
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(21)00328-4openalex-extracted
Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial
inferredcites →https://doi.org/10.1038/bcj.2017.53openalex-extracted
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
inferredcites →https://doi.org/10.1038/s41375-022-01591-4openalex-extracted
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations
inferredcites →https://doi.org/10.1056/nejm194806032382301openalex-extracted
Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)
inferredcites →https://doi.org/10.1056/nejmra052603openalex-extracted
Treatment of Acute Lymphoblastic Leukemia
inferredcites →https://doi.org/10.1056/nejmra1400972openalex-extracted
Acute Lymphoblastic Leukemia in Children
inferredcites →https://doi.org/10.1111/j.1365-2141.2006.06072.xopenalex-extracted
Joe Burchenal and the birth of combination chemotherapy
inferredcites →https://doi.org/10.1111/jcmm.16981openalex-extracted
NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells
inferredcites →https://doi.org/10.1182/blood.v8.11.965.965openalex-extracted
Clinical Evaluation of a New Antimetabolite, 6-Mercaptopurine, in the Treatment of Leukemia and Allied Diseases
inferredcites →https://doi.org/10.1200/jco.1996.14.3.911openalex-extracted
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
inferredcites →https://doi.org/10.1200/jco.2009.25.6115openalex-extracted
Benefits of the Intermittent Use of 6-Mercaptopurine and Methotrexate in Maintenance Treatment for Low-Risk Acute Lymphoblastic Leukemia in Children: Randomized Trial From the Brazilian Childhood Cooperative Group—Protocol ALL-99
inferredcites →https://doi.org/10.1590/s1677-5538.ibju.2022.0318openalex-extracted
Testicular involvement in pediatric acute lymphocytic leukemia: what to do about it?
inferredcites →https://doi.org/10.3389/fonc.2021.797194openalex-extracted
Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group
inferredcites →https://doi.org/10.3390/jcm10204728openalex-extracted
Curing the Curable: Managing Low-Risk Acute Lymphoblastic Leukemia in Resource Limited Countries
inferredcites →https://doi.org/10.3390/jcm11092361openalex-extracted
Editorial to: Advance in the Treatment of Pediatric Leukemia
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.